Back to Market Feed

Product Information

PRIMAQUINE 26.3 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $1.9639 per EA under NDC 50742019105. Its NADAC has been published 91 times since Aug 21, 2024.

FDA first approved this application on Jun 23, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PRIMAQUINE 26.3 MG TABLET

PRIMAQUINE PHOSPHATE
$1.9639per EA

Strength

15 mg/1

NDC

50742019105

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

5/21/2025

Active Ingredients

PRIMAQUINE PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206043

FDA Approved

6/23/2016

TE Code

AB

On Market Since

1/23/2018

Pharmacological Classes

Antimalarial

Price Statistics

The NADAC for PRIMAQUINE 26.3 MG TABLET has been published 91 times since Aug 21, 2024, and over the history we have for it it has risen 17.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.9639 per EA
All-time high$1.9639 (May 13, 2026)
All-time low$1.6638 (Oct 23, 2024)
52-week high$1.9639
52-week low$1.9639
Median price$1.9639
Average price$1.8736
Largest weekly change+14.6% (Mar 19, 2025)
Weeks tracked91
Tracking sinceAug 21, 2024

Price History

1W

N/A

1M

N/A

3M

N/A

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+17.9%

Last surveyed May 13, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PRIMAQUINE PHOSPHATE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

HYDROXYCHLOROQUINE 200 MG TAB
Generic
00093240101•Teva Pharmaceuticals USA Inc.
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
00904704606•Major Pharmaceuticals
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
00904704661•Major Pharmaceuticals
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16571011201•Rising Pharma Holdings Inc.
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16571011250•Rising Pharma Holdings Inc.
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16714011001•NorthStar Rx LLC
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16714011002•NorthStar Rx LLC
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16729048501•Accord Healthcare Inc.
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16729048516•Accord Healthcare Inc.
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
43598072101•Dr. Reddy's Laboratories Inc.
$0.1485
per EA

Frequently asked questions

What is the NADAC price of PRIMAQUINE 26.3 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PRIMAQUINE 26.3 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $1.9639 per EA (NDC 50742019105), effective May 13, 2026.

How has the price of PRIMAQUINE 26.3 MG TABLET changed over time?

Over the history we have for it, the NADAC for PRIMAQUINE 26.3 MG TABLET has risen 17.9%. It has been tracked across 91 weekly CMS publications since Aug 21, 2024.

What are the highest and lowest recorded NADAC prices for PRIMAQUINE 26.3 MG TABLET?

Since Aug 21, 2024, the NADAC for PRIMAQUINE 26.3 MG TABLET has ranged from a low of $1.6638 (Oct 23, 2024) to a high of $1.9639 (May 13, 2026), with a median of $1.9639 per EA.

Are there cheaper alternatives to PRIMAQUINE 26.3 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PRIMAQUINE 26.3 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PRIMAQUINE 26.3 MG TABLET?

PRIMAQUINE 26.3 MG TABLET (NDC 50742019105) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.